Related Experiment Video

Updated: Jan 2, 2026

Measurement of Antibody Effects on Cellular Function of Isolated Cardiomyocytes
13:42

Measurement of Antibody Effects on Cellular Function of Isolated Cardiomyocytes

Published on: March 8, 2013

12.2K

Vibrational spectroscopy as a powerful tool for follow-up immunoadsorption therapy treatment of dilated

Jing Huang1, Anuradha Ramoji1, Shuxia Guo2

  • 1Institute of Physical Chemistry and Abbe Center of Photonics, Helmholtzweg 4, Friedrich-Schiller University, D-07743, Jena, Germany. Ute.Neugebauer@med.uni-jena.de and Leibniz Institute of Photonic Technology, Albert-Einstein-Straße 9, D-07745 Jena, Germany and Center for Sepsis Control and Care, Jena University Hospital, Am Klinikum 1, D-07747 Jena, Germany.

The Analyst
|November 30, 2019
PubMed

Insights

Vibrational spectroscopy offers a non-invasive method to monitor immunoadsorption therapy for dilated cardiomyopathy (DCM). This technique accurately tracks changes in immunoglobulin G levels, reflecting treatment success and patient health stabilization.

Area of Science:

  • Biomedical Spectroscopy
  • Cardiovascular Research
  • Personalized Medicine

Background:

  • Dilated cardiomyopathy (DCM) is a significant heart condition with diverse causes, often necessitating heart transplantation.
  • Immunoadsorption (IA) therapy effectively removes anticardiac antibodies, improving cardiac function in many DCM patients.
  • Non-invasive methods are crucial for evaluating IA therapy's efficacy in DCM management.

Observation:

  • This study utilized label-free vibrational spectroscopy (Raman and IR absorption) to analyze plasma and serum samples from a DCM patient during IA therapy.
  • Chemometric methods were employed to interpret spectral data, identifying distinct patterns at various treatment time points.
  • Changes in immunoglobulin G (IgG) levels were observed and correlated with immunoturbidimetry results.

Findings:

  • Vibrational spectroscopy accurately distinguished different IA treatment time points in both plasma and serum.
  • Spectral changes directly reflected the removal and restoration of IgG during IA therapy.
  • Successful treatment outcomes correlated with significant spectral differences between the initial disease state and long-term follow-up (11 months).
  • Plasma-derived spectra provided higher accuracy in distinguishing treatment time points compared to serum spectra.

Implications:

  • Vibrational spectroscopy serves as a powerful, non-invasive tool for monitoring IA therapy effectiveness in DCM.
  • This approach supports personalized medicine by enabling real-time assessment of treatment response.
  • The findings highlight the potential for spectral analysis to guide and optimize DCM treatment strategies.

More Related Videos

Intra-cardiac Side-Firing Light Catheter for Monitoring Cellular Metabolism using Transmural Absorbance Spectroscopy of Perfused Mammalian Hearts08:51

Intra-cardiac Side-Firing Light Catheter for Monitoring Cellular Metabolism using Transmural Absorbance Spectroscopy of Perfused Mammalian Hearts

Published on: May 12, 2019

7.1K
Vibrational Spectra of a N719-Chromophore/Titania Interface from Empirical-Potential Molecular-Dynamics Simulation, Solvated by a Room Temperature Ionic Liquid08:54

Vibrational Spectra of a N719-Chromophore/Titania Interface from Empirical-Potential Molecular-Dynamics Simulation, Solvated by a Room Temperature Ionic Liquid

Published on: January 25, 2020

5.9K

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
405
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
282
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
210
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
402